George Borak - Procyon VP of Sales - Amerx Health Care Corp
| PCYN Stock | USD 0.24 0.01 4.35% |
VP
Mr. George O. Borak Vice President Sales of Amerx Health Care Corporationration, a subsidiary of Procyon Corporationrationration. Mr. Borak joined Amerx Health Care in June of 2012. Mr. Borak has 33 years of experience in the medical field and 22 years in sales management. Most recently, he was Vice President of Sales and Marketing for Darco International where his duties included managing Sales, Marketing, Customer Service, OEM and International Sales. Prior to that he was in sales and sales management for several orthopedic companies since 2012.
| Age | 62 |
| Tenure | 12 years |
| Phone | 727 447 2998 |
| Web | https://procyoncorp.com |
Procyon Management Efficiency
The company has return on total asset (ROA) of (0.0501) % which means that it has lost $0.0501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0934) %, meaning that it created substantial loss on money invested by shareholders. Procyon's management efficiency ratios could be used to measure how well Procyon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | VP Age | ||
| James Herman | Cumberland Pharmaceuticals | 69 | |
Management Performance
| Return On Equity | -0.0934 | |||
| Return On Asset | -0.0501 |
Procyon Management Team
Elected by the shareholders, the Procyon's board of directors comprises two types of representatives: Procyon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procyon. The board's role is to monitor Procyon's management team and ensure that shareholders' interests are well served. Procyon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procyon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Anderson, CFO, Director and VP of Operations - Amerx Health Care Corporate | ||
| Justice Anderson, Pres CEO | ||
| George Borak, VP of Sales - Amerx Health Care Corp |
Procyon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Procyon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0934 | |||
| Return On Asset | -0.0501 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 8.09 M | |||
| Shares Owned By Insiders | 65.00 % | |||
| Price To Earning | 8.00 X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.40 X |
Pair Trading with Procyon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Procyon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procyon will appreciate offsetting losses from the drop in the long position's value.Moving against Procyon Pink Sheet
| 0.41 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.34 | HPQ | HP Inc | PairCorr |
The ability to find closely correlated positions to Procyon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Procyon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Procyon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Procyon to buy it.
The correlation of Procyon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Procyon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Procyon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Procyon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.